{
    "id": 1771,
    "fullName": "FLT3 L611_E612insCSSDNEYFYVDFREYEYDLKWEFPRENL",
    "impact": "insertion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FLT3 L611_E612insCSSDNEYFYVDFREYEYDLKWEFPRENL results in the insertion of 28 amino acids in the cytoplasmic juxtamembrane region of the Flt3 protein between amino acids L611 and E612 (UniProt.org, PMID: 11756186). L611_E612insCSSDNEYFYVDFREYEYDLKWEFPRENL results in constitutive phosphorylation of Flt3, activation of Stat5 and Mapk signaling, and transformation of cultured cells (PMID: 10698507, PMID: 11756186).",
            "references": [
                {
                    "id": 705,
                    "pubMedId": 11756186,
                    "title": "FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11756186"
                },
                {
                    "id": 12449,
                    "pubMedId": 10698507,
                    "title": "Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10698507"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2322,
        "geneSymbol": "FLT3",
        "terms": [
            "FLT3",
            "CD135",
            "FLK-2",
            "FLK2",
            "STK1"
        ]
    },
    "variant": "L611_E612insCSSDNEYFYVDFREYEYDLKWEFPRENL",
    "createDate": "09/18/2014",
    "updateDate": "10/04/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1040,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, tandutinib (CT53518) inhibited proliferation of cells expressing FLT3 L611_E612insCSSDNEYFYVDFREYEYDLKWEFPRENL in culture (PMID: 12124172).",
            "molecularProfile": {
                "id": 1757,
                "profileName": "FLT3 L611_E612insCSSDNEYFYVDFREYEYDLKWEFPRENL"
            },
            "therapy": {
                "id": 933,
                "therapyName": "Tandutinib",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 749,
                    "pubMedId": 12124172,
                    "title": "CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/12124172"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1757,
            "profileName": "FLT3 L611_E612insCSSDNEYFYVDFREYEYDLKWEFPRENL",
            "profileTreatmentApproaches": [
                {
                    "id": 120,
                    "name": "FLT3 Inhibitor",
                    "profileName": "FLT3 L611_E612insCSSDNEYFYVDFREYEYDLKWEFPRENL"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}